Kelly Jeffery W. 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Jun 19, 2018
Insider Transaction Report
Form 4
Kelly Jeffrey W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-15+15,300→ 15,300 totalExercise: $3.19Exp: 2028-06-15→ Common Stock (15,300 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in quarterly installments starting on June 15, 2018 until the option is fully vested and exercisable on June 15, 2019, subject to continued service.